S
Sérgio Paulo Dejato da Rocha
Researcher at Universidade Estadual de Londrina
Publications - 28
Citations - 314
Sérgio Paulo Dejato da Rocha is an academic researcher from Universidade Estadual de Londrina. The author has contributed to research in topics: Proteus mirabilis & Virulence. The author has an hindex of 8, co-authored 24 publications receiving 213 citations. Previous affiliations of Sérgio Paulo Dejato da Rocha include Instituto Butantan & University of Texas Southwestern Medical Center.
Papers
More filters
Journal ArticleDOI
Detection of diarrheagenic Escherichia coli strains isolated from dogs and cats in Brazil.
Juan J. Puño-Sarmiento,Leonardo Pinto Medeiros,Carolina Chiconi,Fernando H. Martins,Jacinta Sanchez Pelayo,Sérgio Paulo Dejato da Rocha,Jorge Blanco,Miguel Blanco,Marcelo de Souza Zanutto,Renata Kobayashi,Gerson Nakazato,Gerson Nakazato +11 more
TL;DR: It is demonstrated that pets carry virulent DEC genes, which are mainly strains of EPECs and EAECs, and the presence of these virulence factors in isolates from animals without diarrhea suggests that pets can act as a reservoir for human infection.
Journal ArticleDOI
Molecular Detection of HpmA and HlyA Hemolysin of Uropathogenic Proteus mirabilis
Silvia Emanoele Cestari,Marilucia Santos Ludovico,Fernando H. Martins,Sérgio Paulo Dejato da Rocha,Waldir P. Elias,Jacinta Sanchez Pelayo +5 more
TL;DR: The PCR technique has good sensitivity for detecting the hpmA and hpmB genes of P. mirabilis, which are used by the bacteria to damage the kidney tissues.
Journal ArticleDOI
Antibody Therapy for the Control of Viral Diseases: An Update.
Miriam Dibo,Eduardo C Battocchio,Lucas Marcelino dos Santos Souza,Matheus D Veloso da Silva,Bruna Karina Banin-Hirata,Milena Menegazzo Miranda Sapla,Poliana Camila Marinello,Sérgio Paulo Dejato da Rocha,Ligia Carla Faccin-Galhardi +8 more
TL;DR: The present work aims to review the action, obtainment and application of monoclonal antibodies in immunotherapy to control viral diseases.
Journal ArticleDOI
Atypical enteropathogenic Escherichia coli that contains functional locus of enterocyte effacement genes can be attaching-and-effacing negative in cultured epithelial cells.
Sérgio Paulo Dejato da Rocha,Sérgio Paulo Dejato da Rocha,Cecilia M. Abe,Vanessa Sperandio,Silvia Yumi Bando,Waldir P. Elias +5 more
TL;DR: The data indicate that FAS-negative aEPec strains are potentially able to induce A/E in vivo, emphasizing the concern about this test for the determination of aEPEC virulence.
Journal ArticleDOI
Antiviral therapies: advances and perspectives.
Bruna Carolina Gonçalves,Mário Gabriel Lopes Barbosa,Anna Paula Silva Olak,Natalia Belebecha Terezo,Leticia Nishi,Maria Angélica Watanabe,Poliana Camila Marinello,Daniele Zendrini Rechenchoski,Sérgio Paulo Dejato da Rocha,Ligia Carla Faccin-Galhardi +9 more
TL;DR: 96 antivirals approved by the Food and Drug Administration between 1987 and 2019 are summarized and strategies are suggested as inhibitors of viral replication by various means, such as direct binding to the viral particle, blocking the infection, changes in intracellular mechanisms or viral genes, preventing replication and virion formation.